Letter to Stakeholders regarding the Implementation of Safety Features under the Falsified Medicines Directive 2011/62/EU
Please find more information on this topic on the Website of the European Commission here.
published: 18.10.2018
Letter to Stakeholders regarding the Implementation of Safety Features under the Falsified Medicines Directive 2011/62/EU